CTAD 2017

01 - 04 November 2017

The 10th Clinical Trials on Alzheimer’s Disease (CTAD) will take place in Boston, MA from November 1-4, 2017.

At CTAD, clinical trial teams from around the world will report on their work on new biomarkers, the development of sensitive clinical assessment tools to identify those at risk for Alzheimer’s disease and to predict progression, as well as to assess the effectiveness of new treatments.